Sight Sciences, Inc.
NASDAQ:SGHT
3.57 (USD) • At close December 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 20.157 | 21.37 | 19.265 | 18.751 | 20.009 | 23.471 | 18.824 | 20.543 | 18.677 | 17.229 | 14.881 | 14.685 | 13.101 | 12.535 | 8.635 | 8.991 | 8.651 | 3.502 | 6.496 |
Cost of Revenue
| 3.25 | 3.025 | 2.793 | 2.776 | 2.677 | 3.381 | 3.048 | 3.665 | 2.928 | 2.736 | 3.033 | 1.942 | 2.062 | 2.305 | 2.301 | 2.376 | 2.62 | 2.085 | 2.128 |
Gross Profit
| 16.907 | 18.345 | 16.472 | 15.975 | 17.332 | 20.09 | 15.776 | 16.878 | 15.749 | 14.493 | 11.848 | 12.743 | 11.039 | 10.23 | 6.334 | 6.615 | 6.031 | 1.417 | 4.368 |
Gross Profit Ratio
| 0.839 | 0.858 | 0.855 | 0.852 | 0.866 | 0.856 | 0.838 | 0.822 | 0.843 | 0.841 | 0.796 | 0.868 | 0.843 | 0.816 | 0.734 | 0.736 | 0.697 | 0.405 | 0.672 |
Reseach & Development Expenses
| 4.746 | 4.316 | 4.636 | 3.427 | 4.239 | 5.221 | 4.669 | 5.233 | 6.053 | 5.926 | 5.646 | 4.369 | 4.279 | 3.546 | 3.44 | 2.873 | 2.158 | 1.443 | 2.4 |
General & Administrative Expenses
| 0 | 0 | 0 | 21.558 | 0 | 0 | 0 | 26.098 | 0 | 0 | 0 | 20.99 | 0 | 0 | 0 | 11.375 | 0 | 0 | 0 |
Selling & Marketing Expenses
| 0 | 0 | 0 | 2.1 | 0 | 0 | 0 | 2.6 | 0 | 0 | 0 | 2.1 | 0 | 0 | 0 | 0.8 | 0 | 0 | 0 |
SG&A
| 23.39 | 26.68 | 26.559 | 23.658 | 26.504 | 30.056 | 28.675 | 28.698 | 31.541 | 31.431 | 28.395 | 23.09 | 20.79 | 17.76 | 14.55 | 12.175 | 11.228 | 7.664 | 10.678 |
Other Expenses
| 0 | -0.044 | -0.008 | 1.78 | 1.886 | 1.79 | 1.791 | 1.379 | 0.766 | 0.095 | -0.015 | -0.044 | -2.001 | -5.435 | 0.552 | 0.108 | -0.197 | -0.073 | 0.091 |
Operating Expenses
| 28.136 | 30.996 | 31.195 | 27.085 | 30.743 | 35.277 | 33.344 | 33.931 | 37.594 | 37.357 | 34.041 | 27.459 | 25.069 | 21.306 | 17.99 | 15.048 | 13.386 | 9.107 | 13.078 |
Operating Income
| -11.229 | -12.651 | -14.723 | -11.11 | -13.411 | -15.187 | -17.568 | -17.053 | -21.845 | -22.864 | -22.193 | -14.716 | -14.03 | -11.076 | -11.656 | -8.433 | -7.355 | -7.69 | -8.71 |
Operating Income Ratio
| -0.557 | -0.592 | -0.764 | -0.593 | -0.67 | -0.647 | -0.933 | -0.83 | -1.17 | -1.327 | -1.491 | -1.002 | -1.071 | -0.884 | -1.35 | -0.938 | -0.85 | -2.196 | -1.341 |
Total Other Income Expenses Net
| 0.329 | 0.337 | -1.526 | 0.429 | 0.454 | 0.441 | 0.515 | 0.156 | -0.365 | -0.97 | -1.061 | -1.122 | -3.123 | -6.517 | -0.532 | -0.656 | -0.734 | -0.62 | -0.434 |
Income Before Tax
| -10.9 | -12.314 | -16.249 | -10.681 | -12.957 | -14.746 | -17.053 | -16.897 | -22.21 | -23.834 | -23.254 | -15.838 | -17.153 | -17.593 | -12.188 | -9.089 | -8.089 | -8.31 | -9.144 |
Income Before Tax Ratio
| -0.541 | -0.576 | -0.843 | -0.57 | -0.648 | -0.628 | -0.906 | -0.823 | -1.189 | -1.383 | -1.563 | -1.079 | -1.309 | -1.404 | -1.411 | -1.011 | -0.935 | -2.373 | -1.408 |
Income Tax Expense
| 0.166 | 0.015 | 0.017 | 0.01 | 0.078 | 0.008 | 0.014 | 0.01 | 0.019 | 0.009 | 0.009 | 0.098 | 0.016 | 0.022 | 0.052 | 0.016 | 0.008 | 0.006 | 0.031 |
Net Income
| -11.066 | -12.329 | -16.266 | -10.691 | -13.035 | -14.754 | -17.067 | -16.907 | -22.229 | -23.843 | -23.263 | -15.936 | -17.169 | -17.615 | -12.24 | -9.105 | -8.097 | -8.316 | -9.175 |
Net Income Ratio
| -0.549 | -0.577 | -0.844 | -0.57 | -0.651 | -0.629 | -0.907 | -0.823 | -1.19 | -1.384 | -1.563 | -1.085 | -1.311 | -1.405 | -1.417 | -1.013 | -0.936 | -2.375 | -1.412 |
EPS
| -0.22 | -0.25 | -0.33 | -0.22 | -0.27 | -0.3 | -0.35 | -0.35 | -0.46 | -0.5 | -0.49 | -0.34 | -0.43 | -0.42 | -0.29 | -0.26 | -0.23 | -0.24 | -0.26 |
EPS Diluted
| -0.22 | -0.25 | -0.33 | -0.22 | -0.27 | -0.3 | -0.35 | -0.35 | -0.46 | -0.5 | -0.49 | -0.34 | -0.43 | -0.42 | -0.29 | -0.26 | -0.23 | -0.24 | -0.26 |
EBITDA
| -9.591 | -11.069 | -14.853 | -9.14 | -11.365 | -13.001 | -15.389 | -15.353 | -20.769 | -22.573 | -22.029 | -14.464 | -15.725 | -16.157 | -10.813 | -8.325 | -7.007 | -7.545 | -8.567 |
EBITDA Ratio
| -0.476 | -0.587 | -0.754 | -0.582 | -0.576 | -0.571 | -0.838 | -0.763 | -1.119 | -1.31 | -1.48 | -1.005 | -1.177 | -1.305 | -1.27 | -0.926 | -0.81 | -2.175 | -1.301 |